Abstract
Background Globally 20 million children are born with a birth weight below 2,500 grams every year which is considered as a low birthweight (LBW) baby. This study investigates the contribution of modifiable risk factors to inform activities that reduce the rates of LBW in Wales.
Method The cohort (N = 693,377) was comprised of children born between 1st January 1998 and 31st December 2018 in Wales. A multivariable logistic regression model and a predictive model using decision tree were used to investigate the associations between the risk factors and LBW.
Results The study found that non-singleton children had the highest risk of LBW (adjusted odds ratio 21.74, 95% confidence interval (CI) 21.09 – 22.40), followed by pregnancy interval less than one year (2.92, 95% CI 2.70 – 3.15), maternal diabetes (2.03, 95% CI 1.81 – 2.28), maternal hospital admission for anaemia (1.26, 95% CI 1.16 – 1.36), depression (1.58, 95% CI 1.43 – 1.75), serious mental illness (1.46, 95% CI 1.04 – 2.05), anxiety (1.22, 95% CI 1.08 – 1.38) and use of anti-depressant medication during pregnancy (1.92, 95% CI 1.20 – 3.07). Additional maternal risk factors include smoking (1.80, 95% CI 1.76 – 1.84), alcohol-related hospital admission (1.60, 95% CI 1.30 – 1.97), substance misuse (1.35, 95% CI 1.29 – 1.41), living in areas of high deprivation, and evidence of domestic abuse.
Conclusion This work suggests that to address LBW, measures need to focus on improving maternal health, addressing pre-term births, promoting awareness of sufficient pregnancy interval, ensuring adequate support and resources for mother’s mental health and wellbeing.
What is already known on this topic
Each year 6.9% of live births are identified as low birth weight (LBW) in the UK.
LBW children are at risk of poor cognitive development, which is associated with developmental disabilities and poor academic achievement in later life.
The progress to reduce the LBW prevalence in high income regions (including Europe) is not satisfactory to meet World Health Organisation (WHO) LBW target by 2025.
What this study adds
This work has built an e-cohort using data-linkage across multiple routinely collected administrative datasets to investigate the risk factors of LBW for the population of Wales.
Non-singleton children had 22 times higher risk of LBW than singleton children.
Findings suggested that the most important factors to address to reduce the risk of LBW are multiple births, underlying maternal physical (diabetes, anaemia) and mental health, maternal smoking, and substance use (alcohol/drugs), adequate pregnancy interval, higher deprivation, and domestic abuse during pregnancy.
How this study might affect research, practice, or policy
This finding suggests that to address the LBW, adequate support is needed to the mother and their family when they are planning for and during pregnancy.
Multiagency (doctors, midwives, security department) can liaise between them and can take necessary mitigative action to reduce the prevalence of LBW.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by Public Health Wales (PHW), grant number (105186). This work was supported by Nation Institute for Health Research (NIHR), grant number (NIHR133680). This research has been carried out as part of the ADR Wales programme of work. The ADR Wales programme of work is aligned to the priority themes as identified in the Welsh Governments national strategy: Prosperity for All. ADR Wales brings together data science experts at Swansea University Medical School, staff from the Wales Institute of Social and Economic Research, Data and Methods (WISERD) at Cardiff University and specialist teams within the Welsh Government to develop new evidence which supports Prosperity for All by using the SAIL Databank at Swansea University, to link and analyse anonymised data. ADR Wales is part of the Economic and Social Research Council (part of UK Research and Innovation) funded ADR UK (grant ES/S007393/1). This work was also supported by the National Centre for Population Health and Well-Being Research (NCPHWR) which is funded by Health and Care Research Wales. This work was supported by Health Data Research UK which receives its funding from HDR UK Ltd (NIWA1) funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation (BHF) and the Welcome Trust. This work uses data provided by patients and collected by the NHS as part of their care and support. This study used anonymised data held in the Secure Anonymised Information Linkage (SAIL) Databank. We would like to acknowledge all the data providers who enable SAIL to make anonymised data available for research. We acknowledge the support provided by South Wales Police.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study had been approved by the Secure Anonymised Information Linkage Databank independent Information Governance Review Panel (IGRP) (project number 0916 WECC Phase 4).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The linked data have been archived in Secure Anonymised Information Linkage (SAIL) Databank. They are available upon reasonable request to the SAIL databank. https://duckduckgo.com/?t=ffab&q=SAIL++databank&ia=web
